RAIsonance, Inc. Announces BARDA Contract to Continue Development of the AudibleHealth Dx Diagnostic SaMD for COVID-19 and Influenza Through AI-Powered Cough Analysis

RAIsonance’s Forced Cough Vocalization (FCV) Signature Analysis Technology is Designed to Diagnose Respiratory Illnesses Via a Cloud-Based Diagnostic Platform and a Mobile App User Interface DENVER, April 12, 2023 /PRNewswire/ — RAIsonance, Inc., the leader in artificial…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.